Many Medicare patients with advanced cancer receive potentially aggressive treatment at the expense of supportive care, according to a study that analyzed Medicare records. The study, published in ...

Geneos Therapeutics, a clinical-stage biotherapeutics company developing personalized immunotherapies for cancer (PICs), today announced that two patients with aggressive cancers – one with ...

SPRINGFIELD — When Dr. Mark Kenton does his daily rounds, he’s taking the pulse of Mercy Medical Center’s entire Department of Emergency Medicine. Kenton wants to know how many patients are there, how ...

Compared with white patients, Black patients with an aggressive form of leukemia--called acute myeloid leukemia (AML)--were on average more than five years younger at diagnosis and more than 30 ...

Logistic Regression Model to Distinguish Between the Benign and Malignant Adnexal Mass Before Surgery: A Multicenter Study by the International Ovarian Tumor Analysis Group Studies indicate that ...

Evaluation of the Impact of Monitoring for Tumor Lysis During Venetoclax Ramp-Up in Chronic Lymphocytic Leukemia in Routine Clinical Practice We used the National Cancer Database, a hospital-based ...

An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests. The vaccine appears to be safe and effective ...

—Despite the fact that about one-third of patients with ERBB2-positive breast cancer develop brain metastases, not much is known about outcomes among patients who have disease limited to the central ...

New analysis reveals approximately one in four people in England with a type of blood cancer face avoidable delays in diagnosis. Leukaemia UK warned that too many patients are "slipping through the ...